(Q44323220)

English

Locally advanced/inflammatory breast cancers treated with intensive epirubicin-based neoadjuvant chemotherapy: are there molecular markers in the primary tumour that predict for 5-year clinical outcome?

scientific article published in March 2003

Statements

Locally advanced/inflammatory breast cancers treated with intensive epirubicin-based neoadjuvant chemotherapy: are there molecular markers in the primary tumour that predict for 5-year clinical outcome? (English)
H Bonnefoi
S Diebold-Berger
P Therasse
A Hamilton
G MacGrogan
L Shepherd
R Drijkoningen
D Larsimont
M Piccart
1 March 2003
406-413

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit